Mitokinin
About:
Mitokinin is operates in the healthcare industry focusing on biotechnology business.
Website: https://www.mitokinin.com
Top Investors: Mission BioCapital, Pfizer Venture Investments
Description:
Mitokinin is operates in the healthcare industry focusing on biotechnology business. It launches medicinal chemistry effort to generate kinetin analogs optimized for activating PINK1. It plans to develop the analog or optimized variants to treat Parkinson's disease.
Total Funding Amount:
$5M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Francisco, California, United States
Founded Date:
2017-01-01
Founders:
Daniel De Roulet, Kevan Shokat, Nicholas Hertz
Number of Employees:
11-50
Last Funding Date:
2018-10-17
IPO Status:
Private
Industries:
© 2025 bioDAO.ai